131 related articles for article (PubMed ID: 25183426)
1. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
Park MS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Shin SH; Kang W; Moon C; Han KH
Liver Int; 2015 Feb; 35(2):455-62. PubMed ID: 25183426
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Clin Gastroenterol; 2014 Mar; 48(3):272-8. PubMed ID: 23811938
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.
Shin SH; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim BK
Liver Int; 2015 Mar; 35(3):1054-62. PubMed ID: 24930484
[TBL] [Abstract][Full Text] [Related]
4. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
5. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.
Kim BK; Kim SU; Kim HS; Park JY; Ahn SH; Chon CY; Cho IR; Joh DH; Park YN; Han KH; Kim DY
PLoS One; 2012; 7(4):e35825. PubMed ID: 22536445
[TBL] [Abstract][Full Text] [Related]
6. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
[TBL] [Abstract][Full Text] [Related]
7. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.
Lee HW; Yoo EJ; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Han KH
Am J Gastroenterol; 2014 Aug; 109(8):1241-9. PubMed ID: 24957159
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.
Kim BK; Kim HS; Yoo EJ; Oh EJ; Park JY; Kim DY; Ahn SH; Han KH; Kim SU; Park YN
Hepatology; 2014 Dec; 60(6):1911-9. PubMed ID: 25142433
[TBL] [Abstract][Full Text] [Related]
9. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
Seo YS; Kim MN; Kim SU; Kim SG; Um SH; Han KH; Kim YS
Medicine (Baltimore); 2016 Mar; 95(12):e2985. PubMed ID: 27015173
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
[TBL] [Abstract][Full Text] [Related]
11. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
12. Point Shear-Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver-Related Events in Patients With Chronic Viral Hepatitis.
Hernandez Sampere L; Vermehren J; Mücke VT; Graf C; Peiffer KH; Dultz G; Zeuzem S; Waidmann O; Filmann N; Bojunga J; Sarrazin C; Friedrich-Rust M; Mücke MM
Hepatol Commun; 2021 Jan; 5(1):112-121. PubMed ID: 33437905
[TBL] [Abstract][Full Text] [Related]
13. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
Poynard T; Vergniol J; Ngo Y; Foucher J; Thibault V; Munteanu M; Merrouche W; Lebray P; Rudler M; Deckmyn O; Perazzo H; Thabut D; Ratziu V; de Ledinghen V;
J Hepatol; 2014 Nov; 61(5):994-1003. PubMed ID: 25016224
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
Seo YS; Kim MY; Kim SU; Hyun BS; Jang JY; Lee JW; Lee JI; Suh SJ; Park SY; Park H; Jung EU; Kim BS; Kim IH; Lee TH; Um SH; Han KH; Kim SG; Paik SK; Choi JY; Jeong SW; Jin YJ; Lee KS; Yim HJ; Tak WY; Hwang SG; Lee YJ; Lee CH; Kim DG; Kang YW; Kim YS;
Liver Int; 2015 Oct; 35(10):2246-55. PubMed ID: 25682719
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
16. Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song K; Han KH
Medicine (Baltimore); 2016 May; 95(20):e3434. PubMed ID: 27196449
[TBL] [Abstract][Full Text] [Related]
17. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis.
Kim SU; Oh HJ; Wanless IR; Lee S; Han KH; Park YN
J Hepatol; 2012 Sep; 57(3):556-63. PubMed ID: 22617153
[TBL] [Abstract][Full Text] [Related]
18. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
Kim BS; Seo YS; Kim YS; Lee CH; Lee HA; Um SH; Yoo JJ; Kim SG; Suh SJ; Jung YK; Ahn SH; Han KH; Yim HJ; Kim SU;
J Gastroenterol Hepatol; 2018 Feb; 33(2):503-510. PubMed ID: 28666070
[TBL] [Abstract][Full Text] [Related]
19. Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.
Kim BK; Oh HJ; Park JY; Kim DY; Ahn SH; Han KH; Park Y; Yoo EJ; Park YN; Kim SU
Liver Int; 2013 Feb; 33(2):180-9. PubMed ID: 23295050
[TBL] [Abstract][Full Text] [Related]
20. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Liver Int; 2014 Sep; 34(8):1216-23. PubMed ID: 24267737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
